Tsina Georgia, Simon Philippe
Hôpital Erasme, Université Libre de Bruxelles (ULB), Belgium Route de Lennik Lennikse Baan 808, 1070 Anderlecht, Belgium.
Obstet Gynecol Int. 2014;2014:632074. doi: 10.1155/2014/632074. Epub 2014 Apr 22.
Breast MRI focuses on the detection of multifocality, multicentricity, and bilaterality of newly diagnosed breast cancer. A retrospective study was carried out on 833 patients that were diagnosed and treated for breast cancer between January 2002 and December 2011. Patients were divided into two groups: those that had a presurgery breast MRI and those that did not. The two groups were compared on the basis of the several parameters. The aim of the study was to determine whether the use of MRI in breast cancer screening changes the initial treatment decision. In 18% of the patients, MRI revealed a multifocal or a multicentric unilateral breast cancer, a bilateral tumour, or a larger cancer than initially diagnosed. Most of these patients underwent a second-look breast ultrasound, with or without an additional biopsy. The percentage of mastectomies did not increase as a result of an MRI exam. Neoadjuvant chemotherapy was used more often and the percentage of reoperations decreased when an MRI was performed.
乳腺磁共振成像(MRI)主要用于检测新诊断乳腺癌的多灶性、多中心性和双侧性。对2002年1月至2011年12月期间833例确诊并接受治疗的乳腺癌患者进行了一项回顾性研究。患者分为两组:术前接受乳腺MRI检查的患者和未接受该检查的患者。根据几个参数对两组进行比较。该研究的目的是确定在乳腺癌筛查中使用MRI是否会改变初始治疗决策。在18%的患者中,MRI显示为多灶性或多中心性单侧乳腺癌、双侧肿瘤或比最初诊断更大的癌症。这些患者中的大多数接受了二次乳腺超声检查,有或没有额外的活检。MRI检查并未导致乳房切除术的比例增加。当进行MRI检查时,新辅助化疗的使用更为频繁,再次手术的比例降低。